Scott Coiante
Director of Finance/CFO en AGILE THERAPEUTICS, INC. .
Fortuna: 35 012 $ al 31/03/2024
Perfil
Scott M.
Coiante is currently the Chief Financial Officer, CAO & Senior VP at Agile Therapeutics, Inc. He previously worked as the Treasurer, Chief Accounting Officer & VP-Finance at Medarex, Inc. from 2002 to 2010.
Prior to that, he was the Head-Financial Reporting at Ernst & Young LLP from 1989 to 2000.
From 2010 to 2019, he held the position of CFO, Principal Accounting Officer & Senior VP at Agile Therapeutics, Inc. He also served as a Member of the New Jersey Technology Council.
From 2019 to 2023, he was the Chief Financial Officer & Senior Vice President at Aprea Therapeutics AB and Aprea Therapeutics, Inc. He also held the position of Secretary at Aprea Therapeutics, Inc. Mr. Coiante completed his undergraduate degree at Villanova University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
APREA THERAPEUTICS, INC.
0.08% | 26/06/2023 | 4 213 ( 0.08% ) | 28 185 $ | 31/03/2024 |
AGILE THERAPEUTICS, INC.
0.29% | 03/10/2023 | 20 080 ( 0.29% ) | 6 827 $ | 31/03/2024 |
Cargos activos de Scott Coiante
Empresas | Cargo | Inicio |
---|---|---|
AGILE THERAPEUTICS, INC. | Director of Finance/CFO | 16/08/2023 |
Antiguos cargos conocidos de Scott Coiante.
Empresas | Cargo | Fin |
---|---|---|
APREA THERAPEUTICS, INC. | Director of Finance/CFO | 30/01/2023 |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Director of Finance/CFO | 01/01/2023 |
AGILE THERAPEUTICS, INC. | Director of Finance/CFO | 05/08/2019 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Director of Finance/CFO | 01/01/2005 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formación de Scott Coiante.
Villanova University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
AGILE THERAPEUTICS, INC. | Health Technology |
APREA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
New Jersey Technology Council
New Jersey Technology Council Miscellaneous Commercial ServicesCommercial Services New Jersey Technology Council provides business development, education and advocacy services. It serves communications, e-business, multimedia, consumer technologies, manufacturing, engineering and energy sectors. The company was founded in 1996 and is headquartered in New Brunswick, NJ. | Commercial Services |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Scott Coiante